Solid-state characterization of tacrine hydrochloride

Journal of Pharmaceutical and Biomedical Analysis

Volumn 63, Issue , 2012, Pages 53-61

  Sorrenti, Milena ^a   Catenacci, Laura ^a   Bruni, Giovanna ^a   Luppi, Barbara ^b   Bigucci, Federica ^b   Bettinetti, Giampiero ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Differential scanning calorimetry; Fourier transform infrared spectroscopy; Simultaneous thermogravimetric analysis; Tacrine monohydrochloride; X ray powder diffractometry

Indexed keywords

2 PROPANOL; ALCOHOL; METHANOL; TACRINE; WATER;

ALZHEIMER DISEASE; ARTICLE; CHEMICAL STRUCTURE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DISEASE SEVERITY; FOURIER TRANSFORM INFRARED PHOTOACOUSTIC SPECTROSCOPY; HUMIDITY; MELTING POINT; NONHUMAN; PHYSICAL CHEMISTRY; POLARIMETRY; PRIORITY JOURNAL; ROOM TEMPERATURE; SOLID; TEMPERATURE; THERMOGRAVIMETRY; VAPORIZATION; X RAY DIFFRACTION;

1-PROPANOL; 2-PROPANOL; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CHOLINESTERASE INHIBITORS; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; ETHANOL; HUMIDITY; METHANOL; NOOTROPIC AGENTS; POWDER DIFFRACTION; POWDERS; SOLVENTS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TACRINE; TECHNOLOGY, PHARMACEUTICAL; THERMOGRAVIMETRY; TRANSITION TEMPERATURE; WATER;

EID: 84858074510     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.12.023     Document Type: Article

References (22)

1. Hilfiker R., Blatter F., Von Raumer M. Relevance of solid-state properties for pharmaceutical products. Polymorphism in the Pharmaceutical Industry 2006, Wiley-VCH, Germany, pp. 1-19. R. Hilfiker (Ed.).
2. Brittain H.G. Polymorphism and solvatomorphism 2009. J. Pharm. Sci. 2011, 100:1260-1279.
3. Lu J., Rohani S. Polymorphism and crystallization of the active pharmaceutical ingredients (APIs). Curr. Med. Chem. 2009, 16:884-905.
4. Aaltonen J., Allesø M., Mirza S., Koradia V., Gordon K.C., Rantanen J. Solid form screening - a review. Eur. J. Pharm. Biopharm. 2009, 71:23-37.
5. Chieng N., Rades T., Aaltonen J. An overview of recent studies on the analysis of pharmaceutical polymorphs. J. Pharm. Biomed. Anal. 2011, 55:618-644.
6. Griesser U.J. The importance of solvates. Polymorphism in the Pharmaceutical Industry 2006, Wiley-VCH, Germany, pp. 211-233. R. Hilfiker (Ed.).
7. Giron D., Goldbronn C., Mutz M., Pfeffer S., Piechon P., Schwab P. Solid-state characterizations of pharmaceutical hydrates. J. Therm. Anal. Calorim. 2002, 68:453-465.
8. Nordhoff S., Ulrich J. Solvent-induced phase transformation of hydrates. J. Therm. Anal. Calorim. 1999, 57:181-192.
9. Caira M.R., Bettinetti G., Sorrenti M., Catenacci L. Relationships between structural and thermal properties of anhydrous and solvated crystalline forms of brodimoprim. J. Pharm. Sci. 2007, 96:996-1007.
10. Bettinetti G., Caira M.R., Sorrenti M., Catenacci L., Ghirardi M., Fábián L. Thermal studies of solvent exchange in isostructural solvates of a tetroxoprim-sulfametrole complex. J. Therm. Anal. Calorim. 2004, 77:695-708.
11. International Conference on Harmonization (ICH) Guideline Q6A, Test procedures and acceptance criteria for new drug substances and new drug products: chemical substances, vol. 65, Federal Register: December 29, 2000.
12. Giron D., Mutz M., Garnier S. Solid-state of pharmaceutical compounds. Impact of the ICH Q6 guideline on industrial development. J. Therm. Anal. Calorim. 2004, 77:709-747.
13. Summers W.K. Tacrine and Alzheimer's treatments. J. Alzheimers Dis. 2006, 9:439-445.
14. The United States Pharmacopeia Monographs, 34th ed., National Formulary 29, 2011.
15. Davis K.L., Powchik P. Tacrine. Lancet 1995, 345:625-630.
16. Sathyan G., Ritschel W.A., Hussain A.S. Transdermal delivery of tacrine: identification of suitable delivery vehicle. Int. J. Pharm. 1995, 114:75-83.
17. Kankkunen T., Sulkava R., Vuorio M., Kontturi K., Hirvonen J. Transdermal iontophoresis of tacrine in vivo. Pharm. Res. 2002, 19:705-708.
18. Jogani V.V., Shah P.J., Mishra P., Mishra A.K., Misra A.R. Nose-to-brain delivery of tacrine. J. Pharm. Pharmacol. 2007, 59:1199-1205.
19. Luppi B., Bigucci F., Corace G., Delucca A., Cerchiara T., Sorrenti M., Catenacci L., Di Pietra A.M., Zecchi V. Albumin nanoparticles carrying cyclodextrins for nasal delivery of the anti-Alzheimer drug tacrine. Eur. J. Pharm. Sci. 2011, 44:559-565.
20. Zacharias D.E., Glusker J.P. 9-Amino-1,2,3,4-tetrahydroacridine hydrochloride monohydrate (THA·HCl). Acta Crystallogr. C 1988, 44:1656-1658.
21. Bandoli G., Dolmella A., Gatto S., Nicolini M. Solid-state structures and conformational studies of four 1,2,3,3-tetrahydroacridine Alzheimer's disease therapeutics. J. Chem. Crystallogr. 1994, 24:301-310.
22. Handbook of Chemistry and Physics, D.R. Lide, Editor in Chief, 84th ed., CRC Press, 2003-2004, section 6.